Keywords: biotech, holdings, v-411, diabetes, canada, begin, sales

Biotech Holdings' V-411 For Diabetes

Article | 08 April 1996

Print This

Biotech Holdings of Canada will begin sales in China of its recently-approved Type II diabetes drug, V-411, in May. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in